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Abstract
The Coronavirus Disease (COVID-19) has affected 1.8 million people
and resulted in more than 110,000 deaths as of April 12, 2020 [1]. Several
studies have shown that tomographic patterns seen on chest Computed
Tomography (CT), such as ground-glass opacities, consolidations, and
crazy paving pattern, are correlated with the disease severity and pro-
gression [2–6]. CT imaging can thus emerge as an important modality for
the management of COVID-19 patients. AI-based solutions can be used
to support CT based quantitative reporting and make reading efficient
and reproducible if quantitative biomarkers, such as the Percentage of
Opacity (PO), can be automatically computed. However, COVID-19 has
posed unique challenges to the development of AI, specifically concerning
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the availability of appropriate image data and annotations at scale. In
this paper, we propose to use synthetic datasets to augment an existing
COVID-19 database to tackle these challenges. We train a Generative
Adversarial Network (GAN) to inpaint COVID-19 related tomographic
patterns on chest CTs from patients without infectious diseases. Addition-
ally, we leverage location priors derived from manually labeled COVID-
19 chest CTs patients to generate appropriate abnormality distributions.
Synthetic data are used to improve both lung segmentation and segmen-
tation of COVID-19 patterns by adding 20% of synthetic data to the real
COVID-19 training data. We collected 2143 chest CTs, containing 327
COVID-19 positive cases, acquired from 12 sites across 7 countries. By
testing on 100 COVID-19 positive and 100 control cases, we show that
synthetic data can help improve both lung segmentation (+6.02% lesion
inclusion rate) and abnormality segmentation (+2.78% dice coefficient),
leading to an overall more accurate PO computation (+2.82% Pearson
coefficient).
1 Introduction
Coronavirus Disease 2019 or COVID-19 is a rapidly growing pandemic. As of
April 12, 2020, more than 1.8 million people have been affected by the con-
dition worldwide, resulting in over 110,000 deaths [1]. COVID-19 typically
presents with fever, cough and dyspnea, although a significant percentage of
people might be asymptomatic [7]. Estimates show that approximately 20% of
the patients will develop severe symptoms due to pneumonia [6]. While there is
no treatment available at the moment, severe cases require hospitalization for
management of respiratory symptoms and other serious consequences such as
multiple organ failures. The pandemic has caused a severe burden on health-
care systems around the world, leading to a wide range of issues from testing
availability to limited hospital and ICU beds [8, 9]. The disease is confirmed
by an RT-PCR test, which has a sensitivity as low as 70% [10, 11] and might
cause significant delays due to the lack of real-time testing. Recently, the Fleis-
chner Society released recommendations for chest imaging, including CT and
X-ray, for COVID-19 [12]. In an environment with constrained resources, such
as New York City and parts of Italy, Spain, Iran, and China, it is recommended
that chest imaging be used for rapid triage and prioritization of patients in
emergency rooms and hospitals. Even in situations with no serious resource
constraints, it is recommended that chest imaging is performed for patients sus-
pected of COVID-19 with moderate to severe symptoms to establish a baseline
pulmonary status, perform risk stratification, and verify false negatives. Sev-
eral studies have shown that features seen on lung CT, namely ground-glass
opacities (GGO), crazy paving patterns and consolidations, are correlated with
disease severity and progression in COVID-19 [2–6]. For each of the tasks of
triage, severity assessment and progression tracking, the extent of abnormality
must be measured quantitatively. An automated tool that can compute the
extent and severity of CT abnormalities is therefore very useful. In this paper,
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we present an AI system for detection and quantification of abnormalities asso-
ciated with COVID-19. We also present the unique challenges that arise due to
the nature of the COVID-19 emergency and solutions to address each of these
challenges.
Development of an AI system in an emerging outbreak presents several
unique problems, as compared to developing a system for well-known diseases:
• Data. There are well-established and curated databases available for
several pulmonary diseases such as lung cancer (NLST, LUNA, TCIA)
and emphysema (COPDgene). However, COVID-19 is a new disease with
emerging imaging protocols. Collection and curation of chest imaging data
for COVID-19, therefore, provides new challenges.
Technical Challenges: AI systems need a large amount of data for train-
ing, validation and testing. The data needs to be diverse, collected from
multiple countries and hospitals, including several imaging devices to guar-
antee the generalizability of system across diverse patient populations and
imaging devices.
• Clinical or Domain Knowledge. The clinical indications for the role
of imaging has been evolving over the past few months, in parallel to the
development of our project. Likewise, the clinical characterization and
benchmark quantification of the disease is constantly developing. There
are a variety of the CT patterns in the long-tail distribution, variations
in the patient population, variation in the scale, intensity, texture, and
location of pulmonary abnormalities.
Technical Challenges: Ambiguities are present for annotation of data with
respect of boundaries, inclusion criteria and quality control. Existing AI-
dependent pipelines such as landmark detection and organ segmentation
can be broken due to new and severe abnormalities.
• Time Sensitivity. There is an urgent need for technical solutions for
evaluation of COVID-19 due to the enormous burden on public health,
social and economic structures.
Technical Challenges: There is limited time for iterative development of
AI models with limited resources.
To tackle the challenges presented above we propose to generate synthe-
sized data to support the training and development of abnormality detection
and segmentation methods relevant for COVID-19. Additionally, the synthe-
sized data can be leveraged to improve the lung segmentation models without
requiring additional image labelling. In this paper, we propose to inpaint the
main patterns of COVID-19, i.e., GGO, consolidations and crazy paving on to
CT images from control patients. The data synthesis is trained as a 3D GAN
that maps a masked real chest CT image to a chest CT image inpainted with
COVID-19 abnormalities: GGO, consolidations and crazy paving patterns. We
use randomly deformed 3D meshes and spatial probability map, derived from
patients diagnosed with COVID-19, to synthesize the abnormality masks.
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The synthetic data is mixed with real data to improve the performance
of both the lung segmentation and the COVID-19 abnormality detection and
segmentation. We constructed a database of chest CT scans from 327 COVID-19
positive patients from 12 clinical sites across 7 countries. Also, we added chest
CT scans from 471 patients diagnosed with pneumonia patterns and 510 control
patients to the database. By evaluating on a benchmark data set containing 100
COVID-19 positive cases and 100 control patients, we show that the synthetic
data can be helpful to improve the lesion inclusion rate of the lung segmentation
by 6.02% and the precision of automatically computed PO by 3.75% for 2D lesion
segmentation network and 2.82% for the 3D lesion segmentation network.
2 Related Work
2.0.1 AI-aided evaluation for COVID-19
There is limited work done so far in development and deployment of automated
systems for the evaluation of COVID-19. Shan et al showed that a deep learning-
based system can be used to detect and measure the severity of COVID-19 CT
abnormalities [13]. In this work, they used a V-net with a bottle-neck structure
for segmentation of regions affected by COVID-19. Li et al show that COVID-
19 can be differentiated from other types of pneumonia and lung diseases with
the help of a CNN-based classifier [14]. While several papers also show varying
levels of success in classifying COVID-19 vs controls using deep learning methods
[15–17], the role of CT imaging in diagnosis and screening remains debatable
since a percent of patients who test positive for COVID-19 do not show CT
changes. Population studies involving broad testing revealed that out of all
patients who tested positive, 46% of the asymptomatic patients [18], 15% of
the patients with mild symptoms and 5% of the patients with severe symptoms
show no changes on CT. However, the extent of CT abnormalities, when they
are present, are associated with severity and progression [2,3]. Therefore, in this
paper we focus on the quantification of abnormalities associated with COVID-
19.
2.0.2 Image synthesis based data augmentation in medical image
analysis
There has been an increasing interest in synthesizing objects in medical images
to augment existing training set for better diversity due to advances in advances
of generative deep learning models in recent years. Many recent studies proposed
to use generative networks for either transferring the image modalities [19–
22] or inject synthesize objects [23–33] to improve the performance of diverse
medical imaging related AI applications. It was observed in [24] that only adding
the hard synthetic cases into the training set could improve the supervised
model performance with a large margin since the majority of the synthetic
samples would add little values since they can be successfully recognized by
a network that is trained on a large-scale dataset. Thus, authors of [24] use
4
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Figure 1: The data-flow of the training and the inference of the proposed tomo-
graphic pattern synthesis framework.
both the discriminator error and the classification error to select only the hard
synthetic cases to be added to the augmented dataset. In [31], authors proposed
to synthesize hard samples by drawing latent code from a fully differentiable
synthesizer using projected gradient descent. In this work, we use a similar hard-
case sampling approach as [24] since the locations of the synthetic tomographic
patterns are not yet fully differentiable.
3 Methods
3.1 Synthesis of Tomographic COVID-19 Patterns
Given 3D CT images I and the annotated segmentation masks of COVID-19
opacities M , we train a GAN generator to obtain the mapping I = f(I ·M)
to synthesize COVID-19 opacities on arbitrary CT images where · denotes the
filling uniform noise in the masked region. We use a heuristic approach to
synthesize random 3D masks during inference. To avoid intensity bias of the
control lung tissues, the output synthetic images are fused with the original
images using the synthetic masks.
3.1.1 CT Image Synthesis
The 3D chest CT images are re-sampled to the resolution 0.75×0.75×1mm. The
image intensities are normalized to [−1, 1] using the standard lung window with
level -600 and window width 1500. We fill uniform noise with values between
5
[−1, 1] into the image regions annotated with COVID-19 abnormality patterns
thus the patterns are hidden from the generator network. The training 3D
patches are cropped from the normalized images with size 384× 384× 18 each
and are ensured to be centered regarding both lungs. To train the synthesizer
we only keep the positive training patches with annotated COVID-19 patterns.
The generator fG is built with a 3D UNet [34]. For each building block of
the generator, we use the instance normalization [35] followed by a 3 × 3 × 3
convolution layer and LeaklyReLU. The final generator output has the same size
as the input and is activated with the Tanh function. The discriminator network
fD is built with a simple multi-layer CNN. We use the Spectral Normalization
[36] in the discriminator to balance the learning speed of both networks. For
both the real and the fake input to the discriminator, we add a 3D tensor
n ∼ N (0, 0.2) drawn from the Gaussian noise to avoid the discriminator from
pre-maturing during the early iterations. The noise biased inputs are clipped
back to [−1, 1] before being fed to the network.
The objectives for training the synthesizer can be summarized as following
xˆfake = fG(xreal ·m) (1)
LD =‖fD(n+ xreal)− t(1))‖22+
‖fD(n+ xˆfake)− t(0))‖22
(2)
LG =λ1|xfake ◦ ¬m− xˆfake ◦ ¬m|+
λ2|xfake ◦m− xˆfake ◦m|−
LD
(3)
where xreal is the real 3D CT training patch; m is the annotated mask with
COVID-19 patterns; · denotes of operation of filling the uniform noise into the
mask regions. t(.) is a target tensor filled with a constant value (0 or 1) with
the same size as the discriminator output. We use the LSGAN objective which
measures the L2 errors between the discriminator output and the target. ◦
denotes tensor element-wise multiplication. ¬m is the reversed mask that covers
the non-impacted areas. λ1 and λ2 are two hyper-parameters to balance the L1
losses in the COVID-19 affected areas as well as the weight of the discriminator
loss. In all of our experiments, we fixed λ1 = λ2 = 10. We use ADAM to
optimize both networks with the learning rate of 0.001 for generator and 0.004
for the discriminator. In our experiments, we trained a general COVID-19
generator and a consolidation biased generator. The former is trained with all
the annotated COVID19 patterns. The latter is finetuned based on the former
with all the training patches having above −200 mean intensity in the annotated
regions.
To generate synthetic COVID-19 patterns on arbitrary CT images with-
out manual segmentation masks are available, we use the synthetic COVID-19
segmentation masks mˆ as described in Sec. 3.1.2 and mask the image with the
uniform noise injected. The same scaling, cropping, and intensity normalization
is performed as in training. We predict the output volume in a sliding window
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approach by only moving along the z dimension. The window size is fixed as
the same as the training blocks 384×384×18. There is an overlap of 9 between
every two steps. The overlapped region of the generator input is filled with the
output from the previous step to avoid the discontinuity artefacts as shown in
Fig. 2. Thus except the first step, generator predictions are conditioned on the
previous generator outputs.
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Figure 2: The example slices of the model output with input overlap = 0 and
overlap = 9. From left to right are the example slices of axial, coronal and sagit-
tal views. The 3D volume predicted with overlap = 9 shows better consistency
along the z dimension.
We only extract the synthetic abnormality regions from the generator output
and fuse them to the original images since (1) there could be an intensity bias as
shown in Fig. 3 and (2) we cannot guarantee that no other abnormality patterns
hallucinated by the generator as observed in [37] (3) ground glass opacities are
semi transparent in nature and hence the underlying vessels and bronchi are
visible through these opacities. We first blend the output with the original
image with a weighted sum as
xblend = βαxˆ+ (1− β)xcontrol (4)
where β is the constant weight for the synthetic image. We use α to adjust the
intensity of the generated abnormality for areas above -200 HU. The blended
image xblend is then fused to the original image by cropping using the abnor-
mality mask mˆsmooth. The mask boundary is smoothed using a linear distance
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Figure 3: Example axial slices to illustrate the visual difference in different
synthesis settings. From left to right: the original image; the model output
from the generator trained with all the COVID-19 positive images; The output
of fusing the generator output in the second column with the original image;
The output of the generator trained with only high-intensity abnormalities; The
output of fusing the model in the fourth column and the original image. The
first row is obtained by inpainting the patterns on-to a COVID-19 patient using
the same mask manually annotated. The second row is obtained by generating
the COVID-19 patterns on-to a control CT using a synthetic mask.
transform. The output of both models are shown in Fig. 3.
xfinal = xcontrol ◦ ¬mˆsmooth + xblend ◦ mˆsmooth (5)
3.1.2 Mask Synthesis
Our mask synthesis algorithm operates on 3D meshes, giving full control of the
geometry of the synthetic abnormality and ensuring closed shape. Starting from
an initial template closed sphere, we randomly select N points on its surface.
Then, for each point, we apply an affine transformation function of a random
amplitude factor λ. Such transformation is propagated to neighbouring vertices
defined by a distance threshold of δ. Thus, for each sampled vertex vi and each
neighbor vertex nj , the affine factor αj is defined as:
αj = 1 + ((δ − |vi − nj |) ∗ λi)
Additionally, we apply a Laplacian smoothing followed by Humphrey filter-
ing, as proposed in [38]. Finally, we rasterize the resulting mesh to generate a
3D mask using recursive subdivision, as proposed in [39].
The mask of each abnormality connected component is first synthesized in-
dependently as shown in Fig. 5. We then combine them together by taking the
union of all the masks. It is known that COVID-19 usually presents with opac-
ities in subpleural, peripheral, bilateral and multilobar locations. To simulate
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Figure 4: The spatial distribution probability map generated using the COVID-
19 tomographic pattern annotations of the training cases. It is used for sampling
the locations of the synthetic patterns.
(a) N = 10, λ = 1.5 (b) N = 200, λ = 2.5
Figure 5: Example 3D synthetic lesion masks randomly generated with different
parameters.
the spatial distribution of the COVID-19 tomographic patterns, we compute a
spatial probability map using the aligned manual annotations of the COVID-19
positive cases as Fig. 4. We sample the lesion center locations from the prob-
ability map and then map the sampled locations to the corresponding image
space of each image. The combined mask is cropped using the automatically
computed lung mask as shown in Fig. 6.
3.2 Sythesis augmented lung segmentation
During an initial evaluation, a pre-trained DI2IN [40] on 8006 chest CT data
sets (no severe pneumonia patterns) had difficulty to capture the affected areas
on COVID-19 cases, especially heavy consolidation at the posterior bottom
and periphery of the lungs. This directed our investigation to focus on the
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Figure 6: Left: The combined 3D synthetic mask showed with the automatically
computed lung segmentation. Right: The example axial slices drawn from the
synthetic 3D volume generated using the synthetic mask.
affected areas. To start with, 675 and 60 images with moderate pneumonia
patterns are included and annotated for training and validation respectively.
The inclusion of pneumonia cases is helpful, but not sufficient due to the lack of
heavy consolidation that is typical in COVID-19 cases. Therefore, 1530 images
with synthetic consolidation patterns are further included for augmentation.
Meanwhile, a few adjustments during training are applied to adjust for the
inclusion of synthetic data. First, a weighted cross entropy is used to focus
on high intensity areas. Consider x the network input normalized from a CT
image by the center of -624 Hounsfield Unit (HU) and the width of 1500 HU
and clipped to the range of [−1, 1], and p the prediction out of the segmentation
network fS(x), i.e., p = fS(x)., a voxel-wise weighted binary cross entropy is
used that assigns additional attention on high intensity areas inside the lung.
LS = −w[ylog(p) + (1− y)log(1− p)] (6)
w = 1 + γ1
y
1 + exp(−γ2x) (7)
where γ1 and γ2 represents the magnitude and steepness of high intensity ad-
justment. Second, we remove the last skip connection (at the input size level)
from DI2IN to constrain the lung shape despite the presence of the severe con-
solidation.
The training process takes 128× 128× 128 patches randomly sampled from
2×2×2mm3 resampled volumes, and is driven by a learning rate of 0.001 using
the ADAM optimization. The model for the epoch with the best performance
on the validation set is selected.
3.3 Synthesis augmented lesion segmentation
To perform COVID-19 related abnormality segmentation, we use encoder-decoder
based CNN architectures. To learn the relevant COVID-19 patterns, we train
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them on a training dataset from COVID-19, viral pneumonia and other inter-
stitial lung diseases. To analyze the impact of synthetic COVID-19 data for
training, we add them to the training dataset. We utilize both a 2D CNN
approach and a 3D CNN approach. The 2D CNN approach aims to learn high-
resolution in-plane image features by taking three axial slices as input to the
network. We use the 3D CNN approach to efficiently model 3D context with
anisotropic image resolution.
3.3.1 2D
The 2D CNN approach follows the U-Net architecture [34] with an encoder to
model COVID-19 relevant image features and a decoder to generate the segmen-
tation mask. We employ the ResNet-32 architecture [41], in which the feature
encoder uses 5 ResNet blocks consisting of two 3 × 3 convolutions with batch
normalization [42] and ReLU [43], followed by additive identity skip connection.
The decoder has the same number of convolution blocks as in the encoder. The
input to each decoding block is concatenated with the encoding features with
the same resolution. The training images are resampled to have the in-plane
resolution 0.6 × 0.6 mm. Then we compute the geometric center and crop the
images with a fixed bounding box of size 512× 512. We keep the original out-
plane resolution and dimension. The images are clipped by the lung window
with the width 1174 HU and level -150 HU, and then normalized to [-1,1]. The
network is trained with Adam with decoupled weight decay regularization [44].
A soft dice loss [45] is applied to the decoder output prediction to penalize the
difference from ground-truth COVID-19 annotation during training. For data
augmentation, we apply a random mirror flip for in-plane orientations with a
probability of 0.5 and in-plane random translations that are limited to 10 voxels
in each dimension. We perturb the image intensity within a random interval
[−10, 10] HU.
3.3.2 3D
Similar to the network architecture used in [46], we use a variant of the 3D
U-Net network [34] with dense-convolutional blocks [47] and anisotropic feature
computation for higher resolution features and isotropic for lower resolution.
Input CT volumes are pre-processed by resampling them to 1x1x3mm resolu-
tion and cropped based on the lung segmentation to a fixed 384 × 384 × 128
box. Input data is masked by the lung segmentation and normalized using a
standard lung window with width 1500HU and level −600 HU and clipped to
[0, 1]. During training, additional data augmentation is performed by random
intensity perturbation within a [−20, 20] HU interval and random flipping along
x or y directions. The 3D neural network uses convolutional blocks contain-
ing either 1 × 3 × 3 or 3 × 3 × 3 CNN kernels in dense blocks of convolution-
BatchNormalization-LeakyReLU layers. For downsampling the encoder features
are computed using a 1× 2× 2 or 2× 2× 2 convolution layers with a 1× 2× 2
or 2 × 2 × 2 stride and for upsampling transpose-convolution layers are used
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with same kernel sizes. The top two decoder-encoder network levels are using
anisotropic features followed by three isotropic levels. The input to each decoder
block is obtained by concatenating the corresponding encoder output features
with the same resolution with the output of the previous upsampling block. The
final output is using a softmax activation layer. The 3D network is trained using
the AdaBound optimizer [48] which adaptively combines the Adam optimizer
with SGD for faster convergence. We use the Jaccard index as the training loss
function which we found that has stable behavior for imbalanced labels.
Among the advantages of using a 3D architecture is the ability to use 3D
context to deal with in-plane partial volume effects as well as global lung con-
text. Disadvantages include higher computational complexity and potentially
higher complexity and overfitting in training due to a lower number of total
samples. The choice of using anisotropic features is made as a compromise be-
tween computation complexity and having reasonable high-resolution features
computed in the axial acquisition planes.
4 Data
The lung segmentation algorithm and the lesion segmentation algorithm were
developed and evaluated with the dataset summarized in Table. 1. Please note
that not all of the statistics are available due to the various levels of anonymiza-
tion. The lung segmentation and the lesions segmentation were trained on
dedicated datasets to address the challenges specific to each training task. The
performance of the system was evaluated using the same testing set.
The testing set constitutes 100 control images and 100 COVID-19 positive
images. The control group was randomly sampled from the non-pathological
images in NLST [49]. Candidates were identified from the clinical reports and
visually confirmed by a trained user after selection. The 100 COVID-19 posi-
tive patients were sampled from data sources with a clinical confirmation. 110
candidates scans were randomly selected from 2 European and 2 American in-
stitutions. Ten datasets with the lowest Percentage of Opacity (PO) measured
using the ground truth annotations were excluded. All volumes referenced to
the patients selected in the testing set were excluded from any training sets. The
lesion segmentation training set constitutes the remaining 227 COVID positives
cases collected from 10 clinical collaborators, augmented with 174 3D Chest
CTs with pneumonia patterns, 297 cases with interstitial lung diseases. The
lung segmentation training set is made of 735 CT scans with both pathological
(including pneumonia, interstitial lung disease) and control volumes. Please
note that 187 datasets were common to the lesion segmentation training set
and the lung segmentation training. The synthetic images used in this study
are generated based on 510 control images acquired from the COPDGene co-
hort [50]. We synthesized 3 images based on each real control image resulting
in 1530 synthetic images in total.
The original data formats were either DICOM images or 3D Meta-Images.
The 3D CT series were reconstructed from DICOM images by keeping the orig-
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Table 1: Properties of training and testing data used for lung segmentation and
COVID-19 lesion segmentation. IQR: Interquartile rage.
Lung Training Synthetic Data
Input
Lesion Training Testing
Datasets Total: 735, Pneu-
monia: 30, ILD:
705
Control: 510 Total: 698, COVID:
227, Pneumonia: 174,
ILD: 297
Total: 200,
COVID-19: 100,
Control: 100
Data
Origin
Multiple sites in-
cluding sites in
USA, and Belarus
Multiple sites
including sites
in USA
Multiple sites includ-
ing sites in USA,
Canada, Spain,
Switzerland, France,
Czech Republic, and
Germany
Multiple sites in-
cluding sites in
USA, Spain and
Czech Republic
Sex Female: 136,
Male: 208, Un-
known: 391
Female: 84,
Male: 136, Un-
known: 290
Female: 211 , Male:
232, Unknown: 257
Female: 71,
Male: 112,
Unknown: 17
Age
(years)
Median: 64,
IQR: 55.5-70 ,
Unknown: 231
Median: 60,
IQR: 53.5-69,
Unknown: 367
Median: 60, IQR: 54-
67, Unknown: 425
Median: 61,
IQR: 56- 62.25,
Unknown: 64
Scanner
Manu-
facturer
GE: 257,
Siemens: 94,
Philips: 67,
Toshiba: 1,
Other/Unknown:
316
Siemens: 268,
GE: 167,
Philips: 14,
Unknown: 61
Siemens: 349,
GE: 203, Philips:
28, Toshiba: 10,
Other/Unknown: 110
Siemens: 62,
GE: 68, Philips:
24, Toshiba: 28,
Other/Unknown:
18
Slice
Thick-
ness
[mm]
≤ 1.5: 384 ;
(1.5, 3.0]: 230 ; >
3.0: 121
≤ 1.5: 510,
(1.5, 3.0]: 0, >
3.0: 0
≤ 1.5: 381, (1.5, 3.0]:
239 , > 3.0: 78
≤ 1.5: 56,
(1.5, 3.0]: 124,
> 3.0: 20
Recon.
Kernel
Soft: 136, Hard:
321, Unknown:
278
Soft: 510,
Hard: 0,
Unknown: 0
Soft: 94, Hard: 346,
Unknown: 258
Soft: 119, Hard:
81, Unknown: 0
inal resolution and reorienting the volume axially. The annotation of the data
has been formalized as two independent tasks: the annotation of lungs and
the annotation of lesions (COVID-19 opacities, pneumonia and interstitial lung
disease).
4.1 Lung Segmentation Training
The ground-truth for each training data set was generated by expert users with
a custom annotation tool. The user could load anonymized 3D CT series (vol-
ume), interact with the image (including 3 multi-planar reformatted images),
draw and edit contours and mark regions with a pre-specified label for the lungs.
The final mask was saved as a file together with the reference to the original
anonymized CT series. The annotations were reviewed according to internal
quality guidelines. Each annotation was reviewed by a second, more experi-
enced user.
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4.2 Synthesis Augmented Lesion Segmentation Training
The ground-truth for each training data set was generated by expert users with
a 3D editing tool. The user could load anonymized 3D CT series (volume) and
if provided, a pre-computed mask to initialize the annotation. The annotator
would then edit the mask and mark abnormalities such as GGO, consolida-
tion and crazy paving with a pre-specified label. The final mask was saved as
a file together with the reference to the original anonymized CT series. The
annotations were reviewed according to internal quality guidelines. Each anno-
tation was reviewed by a board certified radiologist. The pre-computed masks
were produced by previously trained networks. Only cases a priori identified as
lesion-positive were sent for annotation.
4.3 Synthesis Augmented Lesion Segmentation Testing
The ground-truth was generated using the same approach as for the training
data. In order to perform an inter-rater variability study, 13 random chest CT
data sets from patients diagnosed with COVID-19 were given to two clinical
experts for manual annotations. These 13 cases were randomly selected from
our testing data set of COVID-19 positive patients.
5 Results
5.1 Lung Segmentation
The lung segmentation is a prerequisite for lesion segmentation. Given this, it
is crucial to have the abnormality region fully covered by the lung segmenta-
tion. The performance of different segmentation methods for the inclusion of
abnormalities in the lung mask was not captured by the traditional metrics like
Dice similarity coefficient and average surface distance Therefore, we introduce a
new metric called the lesion inclusion rate, i.e., LIR = |Slesion∩Slung|/|Slesion|.
The LIR is computed for three lung segmentation methods, (a) one only trained
with non-pneumonia data, (b) one fine-tuned with pneumonia data, and (c) one
trained with both pneumonia data and COVID-like synthetic data along with
some tailored adjustments described in section II-B.
From both qualitative (Fig. 8) and quantitative (Fig. 9) results, it can be
seen that the methods trained with high abnormality data demonstrate better
robustness in covering the lung regions with COVID-19 patterns. Without ex-
plicitly training on COVID-19 cases, an average LIR of 0.968 is achieved across
100 COVID positive cases through COVID pattern synthesis and associated
model training adjustments, compared to an average LIR of 0.913 from a base-
line method previously trained over 8000 images.
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Figure 7: Example slices of the lesion segmentation network output overlaid on
the CT axial slices.
5.2 COVID19 Tomographic Pattern Quantification
We show example slices of the lesion segmentation network output overlaid on
the CT axial slices in Fig. 7. Compared to the ground truth, the 3D lesion
segmentation network tends to miss small GGO components as well as the
pleura consolidations. Observing from the middle column of Fig. 7, the synthesis
augmented network (3D Network + Synthetic data) has higher sensitivity for
such challenging regions without producing extra false positives.
We measured the severity of COVID-19 in each subject from predicted seg-
mentation mask by DICE Similarity Coefficient (DSC), Percentage of Opacity
(PO) and Percentage of High Opacity (PHO). The Percentage of Opacity is
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Figure 8: Qualitative results of lung segmentation on example cases with bot-
tom 5%, median, and top 5% lesion inclusion rate among three methods (a)
trained with non-pneumonia images, (b) finetuned on pneumonia images, and
(c) proposed method trained on pneumonia images and synthetic images.
calculated as the total percent volume of the lung parenchyma that is affected
by disease:
PO = 100× volume of predicted abnormalities
volume of lung mask
(8)
The Percentage of High Opacity is calculated as the total percentage volume of
the lung parenchyma that is affected by severe disease i.e., high opacity regions
including consolidation:
PHO = 100× volume of high opacity region
volume of lung mask
(9)
We measured these metrics on 100 COVID-19 positive and 100 control testing
subjects to evaluate the ability of segmentation networks for predicting disease
severity, which is summarized in Table 2. We evaluated 8 different abnormality
segmentation strategies by comparing the following methods: the lung segmen-
tation network finetuned on pneumonia images (Pneumonia Finetuned) vs the
lung segmentation network trained on pneumonia images and synthetic images
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Figure 9: The lesion inclusion rate of the lung segmentation across three meth-
ods (a) trained with non-pneumonia images, (b) fine-tuned on pneumonia im-
ages, and (c) proposed method trained on pneumonia images and synthetic
images
(Pneumonia Finetuned + Syn), the 2D segmentation network (2D) vs the 3D
segmentation network (3D), and the segmentation network trained without syn-
thetic images and the segmentation network trained with synthetic images (20%
of total training images). Using the three metrics, the user variability between
different raters was estimated with 13 COVID-19 positive cases, which is shown
in Table 3.
Table 2: DICE similarity coefficient and Pearson’s correlation coefficient be-
tween predicted disease severity and measures derived from ground-truth for
100 COVID-19 positive and 100 control test cases.
Method DSC Pearson’s correlation on PO Pearson’s correlation on PHO
LungSeg LesionSeg 20% Syn
Pneumonia Finetuned 2D 7 0.6232± 0.1640 0.9078 (p-value = 1.2× 10−76) 0.9063 (p-value = 5.4× 10−76)
Pneumonia Finetuned 2D 3 0.6347± 0.1553 0.9334 (p-value = 4.2× 10−90) 0.9235 (p-value = 2.5× 10−84)
Pneumonia Finetuned 3D 7 0.6565± 0.1727 0.9331 (p-value = 6.9× 10−60) 0.9099 (p-value = 1.3× 10−77)
Pneumonia Finetuned 3D 3 0.6915± 0.1719 0.9591 (p-value = 1.6× 10−110) 0.9218 (p-value = 1.9× 10−83)
Pneumonia Finetuned+Syn 2D 7 0.6348± 0.1588 0.9187 (p-value = 8.5× 10−82) 0.9120 (p-value = 1.4× 10−78)
Pneumonia Finetuned+Syn 2D 3 0.6450± 0.1511 0.9393 (p-value = 6.6× 10−94) 0.9270 (p-value = 2.7× 10−86)
Pneumonia Finetuned+Syn 3D 7 0.6786± 0.1646 0.9307 (p-value = 2.1× 10−88) 0.9317 (p-value = 4.9× 10−89)
Pneumonia Finetuned+Syn 3D 3 0.7064± 0.1586 0.9613 (p-value = 8.7× 10−113) 0.9387 (p-value = 1.7× 10−93)
6 Discussions & Conclusions
Rapid development of an AI system to evaluate CT imaging for COVID-19 is a
challenging task for several reasons. The amount of standardized and curated
CT image data from multiple centers is limited or restricted, the clinical proto-
cols and indications for chest imaging in the disease are evolving as we speak and
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Table 3: User variability between different readers. DICE similarity coefficient
and Pearson’s correlation coefficient (PCC) between two sets of annotated dis-
ease severity measures were used to estimate the user variability for 13 COVID-
19 test cases.
DSC PCC on PO PCC on PHO
0.7132± 0.1831 0.9547 0.9702
(p-value = 4.0× 10−7) (p-value = 4.0× 10−8)
finally, there is an urgent need for a technological solution to ease the burden on
healthcare systems in the middle of a pandemic. In this paper, we propose a so-
lution to these challenges by introducing a framework to synthesize COVID-19
related tomographic patterns in CT images using GAN-based image inpaint-
ing and a 3D shape generation algorithm specific to COVID-19 patterns. In
our work, we use a single abnormality label to annotate all COVID-19 patterns
to train the synthesizer and the abnormality detection networks. Our solution
therefore, not only augments data for training of algorithms, it also implicitly
learns pneumonia patterns most commonly found in COVID-19, such as GGO,
consolidation, and crazy paving pattern.
The synthesizer is trained with 227 COVID-19 positive cases. We evaluate
the impact of adding synthetic data to the lung and abnormality segmentation
networks on a benchmark dataset of 100 COVID-19 positive patients and 100
control subjects. We evaluated the improvement in lung segmentation by a
new metric called lesion inclusion rate or LIR, which measures the coverage
of abnormalities in the lung mask, especially in locations that are common in
COVID-19 such as the periphery. We find that addition of synthetic data im-
proved the PIR by 6.02%. Next, we evaluated the improvement of abnormality
segmentation with the addition of synthetic data. We see that the DSC of the
2D network improved from 0.623 to 0.645 and the DSC of the 3D network im-
proved from 0.657 to 0.706, which is comparable to the inter-user variability
DSC (0.7132 ± 0.1831). Finally, we also report that the Pearson’s correlation
coefficient between the ground truth and predicted metrics improved with net-
works using synthetic data. The PCC for the PO improved from 0.908 to 0.939
for the 2D network and 0.933 to 0.961 for the 3D network, which is comparable
to the inter-user variability range (PCC = 0.957). Likewise, the PCC for the
PHO improved from 0.906 to 0.927 for the 2D network and 0.9099 to 0.9387
for the 3D network. We demonstrate in this paper that the addition of syn-
thetic data improves the quality of lung segmentation by including the regions
of high abnormality, which also translates to an improvement in abnormality
segmentation.
Limitations: At the moment we focused on the most prevalent patterns
seen on chest CT images from COVID-19 confirmed patients, namely ground-
glass opacities, consolidations and crazy paving patterns. Other abnormalities
associated less frequently with chest CT images from COVID-19 patients such
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as atelectasis, interlobular septal thickening, pleural effusions and bronchiectasis
are also present in our data set. However, we did not focus on synthesizing or
validating our existing system on these specific findings.
Disclaimer: The concepts and information presented in this paper are based
on research results that are not commercially available
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